Journal of Drug Targeting

Papers
(The TQCC of Journal of Drug Targeting is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Nose-to-brain delivery of transferrin-modified carmustine-loaded iron nanoparticles for enhanced glioblastoma treatment76
Polymyxin B delivery systems: smart solutions for improved antibacterial activity and reduced toxicity61
Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma49
Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma44
Advancement in transporter-oriented nanoplatforms for cancer therapy43
Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances38
Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches36
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis33
Advances in nanomedicine for retinal drug delivery: overcoming barriers and enhancing therapeutic outcomes31
Role of curcumin and its nanoformulations in the treatment of neurological diseases through the effects on stem cells31
Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer29
Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases29
Beyond drug delivery: nanoparticles as active modulators of immunometabolism for treating inflammatory diseases28
Correction28
Improved antidiabetic potential of quercetin-loaded chitosan–lecithin nanoparticles for effective glycaemic control26
Emerging role of ferroptosis in diabetic retinopathy: a review26
Chitosan–β-glycerophosphate thermogelling microneedles for transdermal contraceptive delivery of levonorgestrel25
Exosomes derived from cancer cells relieve inflammatory bowel disease in mice24
Sequential targeting dual-responsive magnetic nanoparticle for improved therapy of lung metastatic breast cancer24
The role of MSC-derived exosomes in immune modulation and regenerative medicine23
Correction23
Interactions and communications in lung tumour microenvironment: chemo/radiotherapy resistance mechanisms and therapeutic targets23
Engineered extracellular vesicle with RAGE-antagonist peptide for delivery of anti-miRNA155 oligonucleotides to inflammatory lung cells23
Ferroptosis-targeting drugs in breast cancer23
Absorption enhancer approach for protein delivery by various routes of administration: a rapid review23
Pravastatin-Loaded nanostructured lipid carriers: formulation optimization and in-vivo assessment for antihyperlipidaemic effect in rats22
Crafting two-dimensional materials for contrast agents, drug, and heat delivery applications through green technologies22
In vivo application of magnetic molecularly imprinted polymer in rheumatoid arthritis rat model21
Redefining hepatocellular carcinoma treatment: nanotechnology meets tumor immune microenvironment20
Isoform-specific vs. isoform-universal drug targeting: a new targeting paradigm illustrated by new anti-ICAM-1 antibodies20
Stimulus-responsive peptide hydrogels: a safe and least invasive administration approach for tumor treatment20
Recent progress in biomimetic nanomedicines based on versatile targeting strategy for atherosclerosis therapy19
Redox responsive functionalised mesoporous silica nanoparticle for targeted drug delivery of doxorubicin19
Thermosensitive, injectable, biocompatible epigallocatechin gallate liposomes/modified chitosan composite hydrogel for efficient skin repairing19
Comprehensive insights into herbal P-glycoprotein inhibitors and nanoformulations for improving anti-retroviral therapy efficacy18
Therapeutic potential of mesenchymal stem cells-derived exosomes loaded with elemental or nano selenium on diabetic nephropathy18
Formulation, optimisation, and evaluation of Lornoxicam-loaded Novasomes for targeted ulcerative colitis therapy: in vitro and in vivo investigations18
Emerging trends in viral infection inhibition using a chitosan-based drug delivery system18
Dehydrocurvularin-loaded mPEG-PLGA nanoparticles for targeted breast cancer drug delivery: preparation, characterization, in vitro , and in vivo 18
siRNA targeting PARP-1 alleviates diabetic peripheral neuropathy in a streptozotocin-induced rat model18
Targeting lipopolysaccharides in gram-negative sepsis: therapeutic advances and challenges17
pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery17
Identifying factors controlling cellular uptake of gold nanoparticles by machine learning17
Lipo/TK-CDN/TPP/Y6 nanoparticles inhibit cutaneous melanoma formation16
Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells16
The role of green synthesis metal and metal oxide nanoparticles in oral cancer therapy: a review15
Targeted delivery of epirubicin to cancerous cell using copper sulphide nanoparticle coated with polyarginine and 5TR1 aptamer15
L-Carnosine loaded chondroitin sulphate functionalized proposomes as an effective tool for transdermal rheumatoid arthritis management15
Targeting osteoporosis: Rutin-loaded proniosomes and their role in OPG/RANKL modulation in ovariectomized rats15
Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review14
From adhesion to invasion: the multifaceted roles of Mycobacterium tuberculosis lipoproteins14
microRNAs: critical targets for treating rheumatoid arthritis angiogenesis14
Angiopep-2 modified dual drug-loaded liposomes with brain targeting functionality mitigate Alzheimer’s disease-related symptoms in APP/PS-1 mice14
Emerging biologics for the treatment of pulmonary arterial hypertension14
Multi-pathway therapeutics in colorectal cancer: targeting EMT, CSCs, and non-apoptotic cell death for drug resistance reversal13
The Golgi apparatus as a strategic target in cancer: mechanisms, diagnosis and therapeutic opportunities13
Recent advances in curcumin-based nanoformulations in diabetes13
Exploring the translocation behaviours in vivo of herpetrione amorphous nanoparticles via oral delivery13
Research progress of p38 as a new therapeutic target against morphine tolerance and the current status of therapy of morphine tolerance13
A novel micellar carrier to reverse multidrug resistance of tumours: TPGS derivatives with end-grafted cholesterol13
Folate receptor-mediated targeted therapy for rheumatoid arthritis by methotrexate-phospholipid complex nano-emulsions13
An overview of phospholipid enriched-edge activator-based vesicle nanocarriers: new paradigms to treat skin cancer13
Multi-strategic approaches for enhancing active transportation using self-emulsifying drug delivery system13
Study on lipid nanomicelles targeting placenta for the treatment of preeclampsia13
Recent developments in nanoparticles for the treatment of diabetes13
Solvent-free green preparation of niacinamide niosomes for targeting UVB-induced hyperpigmentation: QbD-based optimisation and in vivo assessment12
Edoxaban enfolded beta-1,4-poly- d -glucosamine nanoparticles for targeting eponym Stuart–Prower factor for treatment of venous thrombosis12
In vitro studies support clinical trials showing platelet-rich fibrin-mediated local delivery of antibiotics improves outcomes in impacted mandibular third molar surgery12
Valeric acid reduction by chitosan oligosaccharide induces autophagy in a Parkinson’s disease mouse model12
Methotrexate-Loaded solid lipid nanoparticles enhance the viability of cutaneous flaps: potential for surgical wound healing12
Green synthesis of magnesium oxide nanoparticles using the extract of Falcaria vulgaris to enhance the healing of burn wounds12
Boosting breast cancer immunotherapy through targeted siRNA delivery and sequential chemotherapy12
MicroRNA-206 inhibition and activation of the AMPK/Nampt signalling pathway enhance sevoflurane post-conditioning-induced amelioration of myocardial ischaemia/reperfusion injury12
Pulmonary delivery of a recombinant RAGE antagonist peptide derived from high-mobility group box-1 in a bleomycin-induced pulmonary fibrosis animal model12
ceRNA networks in gynecological cancers progression and resistance11
Nanotransethosomal dual-drug loaded gel of methotrexate and mangiferin as a potent synergistic intervention for rheumatoid arthritis via transdermal delivery11
A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches11
Smart design and preclinical evaluation of folate-functionalized mesoporous nanoparticles for targeted paclitaxel delivery in cancer therapy11
Development of mRNA nano-vaccines for COVID-19 prevention and its biochemical interactions with various disease conditions and age groups11
Development of linagliptin-loaded liposomes using aspartic acid conjugate for bone-targeted delivery to combat osteoporosis11
Lymphatic targeting for therapeutic application using nanoparticulate systems11
ROS1-positive non-small cell lung cancer (NSCLC): biology, diagnostics, therapeutics and resistance11
Nanoparticle-Based gene therapy strategies in retinal delivery11
Role of liposomes in chemoimmunotherapy of breast cancer10
Olaparib@human serum albumin nanoparticles as sustained drug-releasing tumour-targeting nanomedicine to inhibit growth and metastasis in the mouse model of triple-negative breast cancer10
Anti-GPC3 antibody and cell-penetrating peptide CPP44 dual-ligand modified liposomes for targeted delivery of arsenic trioxide in the treatment of hepatocellular carcinoma10
Calpeptin promotes osteogenesis through the Dlx3–RUNX2 pathway: in vitro and in vivo evidence for a dual-action osteoporosis therapy10
Development of venlafaxine hydrochloride nasal thermosensitive in-situ gel with P407/P188: enhanced bioavailability and antidepressant effects in depressive rats10
Mannosylated chitosan-decorated PLGA nanoparticles for targeted pulmonary delivery of isoniazid: a promising approach in the treatment of tuberculosis10
Advancements in colorectal cancer immunotherapy: from CAR-T cells to exosome-based therapies10
Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target10
Empagliflozin alleviates myocardial I/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK/ATF4/Beclin1 pathway10
Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy10
The combined treatment of gold nanoparticles associated with photobiomodulation accelerate the healing of dermonecrotic lesion10
Advancement on nanoparticles-based approaches for the management of rheumatoid arthritis (RA): molecular mechanism, toxicity, and clinical perspectives9
Chemical modification of curcumin increases its potency against hypopharyngeal carcinoma9
Recent advancements in nanomedicine based lipid metabolism for tumour immunotherapy9
DOX-loaded mesoporous hydroxyapatite modified by hyaluronic acid can achieve efficient targeted therapy for lung cancer9
Albumin-encapsulated HSP90-PROTAC BP3 nanoparticles not only retain protein degradation ability but also enhance the antitumour activity of BP3 in vivo9
Fisetin topical delivery via ascorbyl palmitate/hyaluronan-enhanced limosomes: a novel paradigm for preventing UVB-induced skin photoaging9
Octreotide and Octreotide-derived delivery systems9
Integrating machine learning and multitargeted drug design to combat antimicrobial resistance: a systematic review9
2,2,6,6-tetramethylpiperidin-1-oxyl: a new potential targeted ligand based on lipid peroxidation for targeted drug delivery9
Aptamers: ushering in new hopes in targeted glioblastoma therapy9
Patient-derived organoid models of malignant phyllodes tumours for drug sensitivity testing and identification of targeted therapeutic strategies9
Enhanced pharmacokinetic approach for anastrozole via macromolecule-based silk fibroin nanoparticles incorporated in situ injectables for oestrogen-positive breast cance9
Venlafaxine suppressed PD-L1 expression through oxidative stress and improved anti-tumour immune responses in melanoma mice8
Nanotechnology-driven approaches for the early detection and targeted treatment of Alzheimer’s disease8
Exploring the potential of ferulic acid-loaded nanostructured lipid carriers: angiotensin inhibition via docking, formulation and pharmacokinetic and pharmacodynamics studies8
Formulation and optimisation of nanoemulsions for enhancing topical delivery of methotrexate in CFA induced arthritis rat model8
Comparison of a poloxamer-based thermally sensitive gel and an HPMC-based standard gel used to increase sildenafil citrate retention in the uterus8
Synergistic antibacterial and antibiofilm activity of N-acetylcysteine combined with niosomal recombinant lysostaphin against MRSA Staphylococcus aureus8
Efficacy of intranasal delivery of VEGFR inhibitors to cervical lymph nodes for inhibiting tongue cancer metastasis in mice8
Protein biomarker modulation and wound healing efficacy of mentha piperita-based green-synthesized silver nanoparticles in alloxan-induced diabetic rats8
Platelet-rich plasma ameliorates knee osteoarthritis in rats by modulating the abundance of gut Lactobacillus murinus8
Fabrication of crosslinker-free chitosan-HPMC hydrogel for implant coating: a new approach for the treatment of osteomyelitis8
Celastrol nano-emulsions selectively regulate apoptosis of synovial macrophage for alleviating rheumatoid arthritis8
Preparation of cationic liposomes loaded with Sirtuin 6 plasmid for the treatment of arthritis in rats8
Advanced co-delivery nanocarriers to overcome drug resistance in breast cancer: carrier-mediated synergistic treatment by chemotherapy and gene therapy8
Dectin-1 receptor-targeted β-glucan microparticles as dry powder inhalation system – a novel strategy to improve lung pharmacokinetics of rifampicin8
Bone morphogenetic protein (BMP)9 in cancer development: mechanistic, diagnostic, and therapeutic approaches?8
A review of recombinant HER3 affibodies with an effective diagnostic view of cancer cells8
Molecular mechanism of Wilms tumour 1-associated protein in diabetes-related dry eye disease by mediating m6A methylation modification of lncRNA NEAT18
Ofirnoflast: a first-in-class NEK7-targeted inhibitor of the NLRP3 inflammasome8
Methodological advances in liposomal encapsulation efficiency determination: systematic review and analysis8
Molecular and cellular biology of PCSK9: impact on glucose homeostasis8
Research progress of microneedle drug delivery system in the treatment of autoimmune diseases8
0.2861499786377